{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-007004","form_type":"8-K","ticker":"NEPH","cik":"0001196298","company_name":"NEPHROS INC","filed_at":"2023-03-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.081373+00:00","generated_at":"2026-06-18T08:14:43.061096+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Nephros reports FY2022 net revenue $10M; net loss widens to $4.3M; subsidiary SRP winding down","bullets":["Net revenue from continuing operations: $10.0M in FY2022 (-2% YoY); Q4 $2.6M (-6% YoY).","Net loss from continuing operations: $4.3M in FY2022 vs $2.8M loss in 2021; Q4 loss $0.7M flat.","Gross margins improved to 59% in Q4 (vs 54% prior year); full-year margins 47% (vs 55%).","Majority-owned subsidiary SRP to wind down after failing to find strategic partner; expects cessation in Q2 2023.","Cash and equivalents $3.6M at Dec 31, 2022; targeting cash flow breakeven by mid-2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-007004","json":"https://secwatch.observer/filing/0001493152-23-007004.json","markdown":"https://secwatch.observer/filing/0001493152-23-007004.md","text":"https://secwatch.observer/filing/0001493152-23-007004.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1196298/000149315223007004/0001493152-23-007004-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1196298/000149315223007004/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T08:14:43.061096+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c4bb236ce1880b8b88cf28f13af1507b92278810","claim":"NEPHROS INC reported fourth quarter and fiscal year ended December 31, 2022 results: revenue $2.6 million (Q4); $10.0 million (FY), net income ($0.7 million) (Q4); ($4.3 million) (FY).","evidence_excerpt":"Nephros Announces Fourth Quarter and Fiscal Year 2022 Financial Results Full-Year Net Revenue of $10 Million and Fourth Quarter Net Revenue of $2.6 Million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1196298/000149315223007004/0001493152-23-007004-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter and fiscal year ended December 31, 2022"},{"label":"Revenue","value":"$2.6 million (Q4); $10.0 million (FY)"},{"label":"Net income","value":"($0.7 million) (Q4); ($4.3 million) (FY)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}